On the normative foundations of pharmaceutical regulation

David Teira, On the normative foundations of pharmaceutical regulation. Barbara Osimani y Adam LaCaze, 2017 (bookPart)

Ficheros (Some files may be inaccessible until you login with your e-spacio credentials)
Nombre Descripción Tipo MIME Size
NormativeFoundationsPharmaceuticalRegulation.pdf NormativeFoundationsPharmaceuticalRegulation.pdf application/pdf 361.14KB
Título On the normative foundations of pharmaceutical regulation
Autor(es) David Teira
Materia(s) Filosofía
Abstract I argue that behind the 1962 Food and Drug Administration Act we find a combination of two normative principles: a liberal argument for the protection of pharmaceutical markets (in terms of quality control) and a paternalist argument for the protection of pharmaceutical consumers (in terms of drug safety and efficacy). These normative intuitions go hand in hand with the choice of regulatory testing standards: depending on the values the regulator wants to protect, she will avail herself of different testing methods. I explore two potential justifications for regulatory paternalism, in terms of risk aversion and impartiality. I defend our current regulatory arrangement against socialist and libertarian critiques.
Palabras clave FDA
clinical trials
Editor(es) Barbara Osimani
Adam LaCaze
Fecha 2017-06-08
Formato application/pdf
Identificador bibliuned:501107
Versión de la publicación acceptedVersion
Nivel de acceso y licencia http://creativecommons.org/licenses/by-nc-nd/4.0
Tipo de recurso bookPart
Tipo de acceso Abierto
Notas adicionales A. La Caze & B. Osimani, eds., Uncertainty in Pharmacology, Cham, Springer, 2020, 417-438.

Versión Tipo de filtro
Contador de citas: Google Scholar Search Google Scholar
Estadísticas de acceso: 735 Visitas, 178 Descargas  -  Estadísticas en detalle
Creado: Sat, 10 Jun 2017, 00:33:31 CET by David Teira